Kappa-opioid receptor antagonism in the nucleus accumbens shell distinguishes escalated alcohol consumption and negative affective-like behavior from physiological withdrawal in alcohol-dependence

Pharmacol Biochem Behav. 2024 Oct:243:173840. doi: 10.1016/j.pbb.2024.173840. Epub 2024 Aug 7.

Abstract

Alcohol use disorder (AUD) is a chronic relapsing disease that is deleterious at individual, familial, and societal levels. Although AUD is one of the highest preventable causes of death in the USA, therapies for the treatment of AUD are not sufficient given the heterogeneity of the disorder and the limited number of approved medications. To provide better pharmacological strategies, it is important to understand the neurological underpinnings of AUD. Evidence implicates the endogenous dynorphin (DYN)/κ-opioid receptor (KOR) system recruitment in dysphoric and negative emotional states in AUD to promote maladaptive behavioral regulation. The nucleus accumbens shell (AcbSh), mediating motivational and emotional processes that is a component of the mesolimbic dopamine system and the extended amygdala, is an important site related to alcohol's reinforcing actions (both positive and negative) and neuroadaptations in the AcbSh DYN/KOR system have been documented to induce maladaptive symptoms in AUD. We have previously shown that in other nodes of the extended amygdala, site-specific KOR antagonism can distinguish different symptoms of alcohol dependence and withdrawal. In the current study, we examined the role of the KOR signaling in the AcbSh of male Wistar rats in operant alcohol self-administration, measures of negative affective-like behavior, and physiological symptoms during acute alcohol withdrawal in alcohol-dependence. To induce alcohol dependence, rats were exposed to chronic intermittent ethanol vapor for 14 h/day for three months, during which stable escalation of alcohol self-administration was achieved and pharmacological AcbSh KOR antagonism ensued. The results showed that AcbSh KOR antagonism significantly reduced escalated alcohol intake and negative affective-like states but did not alter somatic symptoms of withdrawal. Understanding the relative contribution of these different drivers is important to understand and inform therapeutic efficacy approaches in alcohol dependence and further emphasis the importance of the KOR/DYN system as a target for AUD therapeutics.

Keywords: Alcohol; Alcohol use disorder; Dynorphin; Dysregulation; Elevated plus maze; Ethanol; Extended amygdala; Forced swim test; Kappa opioid receptor; Maladaptive behavioral regulation; Nucleus accumbens; Pharmacotherapy; Physiological withdrawal; Self-administration; Somatic withdrawal; Ultrasonic vocalization.

MeSH terms

  • Alcohol Drinking* / psychology
  • Alcoholism* / drug therapy
  • Alcoholism* / metabolism
  • Alcoholism* / psychology
  • Animals
  • Behavior, Animal / drug effects
  • Ethanol / administration & dosage
  • Ethanol / pharmacology
  • Male
  • Narcotic Antagonists / pharmacology
  • Nucleus Accumbens* / drug effects
  • Nucleus Accumbens* / metabolism
  • Pyrrolidines / administration & dosage
  • Pyrrolidines / pharmacology
  • Rats
  • Receptors, Opioid, kappa* / antagonists & inhibitors
  • Receptors, Opioid, kappa* / metabolism
  • Self Administration
  • Substance Withdrawal Syndrome* / drug therapy
  • Substance Withdrawal Syndrome* / metabolism
  • Substance Withdrawal Syndrome* / psychology

Substances

  • Receptors, Opioid, kappa
  • Ethanol
  • Narcotic Antagonists
  • Pyrrolidines